Skip to main content

Table 3 Univariate analysis comparing OS and RFS in breast cancer

From: Proteomic analysis of breast cancer based on immune subtypes

Factors

OS

p

RFS

p

Hazard Ratio (95% CI)

Hazard Ratio (95% CI)

Age (≥ 50 vs. < 50)

1.990 (0.495–7.999)

0.332

1.475 (0.523–4.161)

0.463

Intrinsic subtypes

 HR + HER2- (ref.)

1

 

1

 

 HR + HER2 + 

3.572 (0.223–57.127)

0.368

0.593 (0.071–4.942)

0.629

 HR− HER2 + 

0.000

 − 

0.542 (0.065–4.519)

0.572

 TNBC

7.422 (0.911–60.480)

0.061

1.712 (0.620–4.727)

0.299

pCR vs. non-pCR

0.026 (0.000–8.589)

0.217

0.221 (0.050–0.964)

0.045*

RCB class

 0

0.000

 − 

0.166 (0.030–0.909)

0.038*

 I

0.000

 − 

0.000

 − 

 II

1.009 (0.209–4.859)

0.991

0.838 (0.270–2.604)

0.760

 III (ref.)

1

 

1

 

Immune subtypes

 Excluded/Desert (ref.)

1

 

1

 

 Inflamed

1.716 (0.428–6.882)

0.446

1.150 (0.437–3.027)

0.777

TILs (≥ 10% vs. < 10%)

1.872 (0.467–7.505)

0.376

1.110 (0.437–2.819)

0.826

TILs (%)

1.019 (0.988–1.051)

0.242

1.006 (0.978–1.034)

0.690

Klintrup criteria (2,3 vs. 0,1)

2.393 (0.496–11.543)

0.277

1.175 (0.434–3.182)

0.752

TLS score (2,3 vs. 0,1)

3.360 (0.900–12.544)

0.071

2.494 (0.920–6.761)

0.073

Stroma (≥ 50% vs. < 50%)

0.495 (0.133–1.845)

0.295

0.742 (0.293–1.881)

0.530

  1. OS overall survival, RFS relapse-free survival, CI confidence interval, p p-value, pCR pathologic complete response, RCB residual cancer burden, TILs tumor-infiltrating lymphocytes, TLS tertial lymphoid structure *p < 0.05